Dolby Laboratories (DLB) Expected to Post Quarterly Earnings on Tuesday

Dolby Laboratories (NYSE:DLB) is projected to post its Q4 2026 results after the market closes on Tuesday, November 17th. Analysts expect the company to post earnings of $1.19 per share and revenue of $372.76 million for the quarter. Interested persons can check the company’s upcoming Q4 2026 earnings overview page for the latest details on the call scheduled for Tuesday, November 17, 2026 at 5:00 PM ET.

Dolby Laboratories Stock Performance

DLB stock opened at $64.75 on Tuesday. The company’s 50 day moving average price is $60.77 and its 200 day moving average price is $59.38. The firm has a market capitalization of $6.07 billion, a price-to-earnings ratio of 27.55 and a beta of 0.79. Dolby Laboratories has a fifty-two week low of $48.26 and a fifty-two week high of $69.95.

Dolby Laboratories declared that its Board of Directors has initiated a share repurchase program on Thursday, July 30th that permits the company to repurchase $350 million in outstanding shares. This repurchase authorization permits the electronics maker to purchase up to 7% of its shares through open market purchases. Stock repurchase programs are typically a sign that the company’s leadership believes its shares are undervalued.

Analysts Set New Price Targets

DLB has been the subject of several analyst reports. Zacks Research cut shares of Dolby Laboratories from a “hold” rating to a “strong sell” rating in a report on Thursday, October 15th. Weiss Ratings upgraded shares of Dolby Laboratories from a “sell (d+)” rating to a “hold (c-)” rating in a report on Wednesday, September 9th. Rosenblatt Securities restated a “buy” rating and issued a $85.00 price objective on shares of Dolby Laboratories in a report on Friday, August 28th. Finally, Wall Street Zen cut shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research report on Saturday, August 1st. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $87.50.

Insider Buying and Selling

In other Dolby Laboratories news, SVP John D. Couling sold 7,667 shares of the company’s stock in a transaction on Thursday, October 1st. The shares were sold at an average price of $58.78, for a total value of $450,666.26. Following the completion of the transaction, the senior vice president owned 166,803 shares in the company, valued at $9,804,680.34. This represents a 4.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP Shriram Revankar sold 3,000 shares of the company’s stock in a transaction on Friday, August 14th. The shares were sold at an average price of $62.71, for a total transaction of $188,130.00. Following the completion of the transaction, the senior vice president owned 73,274 shares of the company’s stock, valued at $4,595,012.54. This represents a 3.93% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold 19,517 shares of company stock worth $1,184,093 in the last ninety days. 37.93% of the stock is owned by corporate insiders.

About Dolby Laboratories

Dolby Laboratories, Inc develops audio and imaging technologies used in entertainment and consumer electronics. Its offerings include Dolby Atmos immersive audio, Dolby Vision high-dynamic-range imaging, and technologies for encoding, delivering and reproducing sound and video.

The company licenses its technologies to manufacturers and content businesses across areas such as film, television, streaming, gaming and mobile devices. Dolby also supports cinema experiences through technologies and services including Dolby Cinema.

Founded by Ray Dolby in 1965, the company serves customers and partners worldwide.